30.57
price down icon0.65%   -0.20
after-market Handel nachbörslich: 31.79 1.22 +3.99%
loading
Schlusskurs vom Vortag:
$30.77
Offen:
$30.93
24-Stunden-Volumen:
296.64K
Relative Volume:
0.55
Marktkapitalisierung:
$1.14B
Einnahmen:
$154.15M
Nettoeinkommen (Verlust:
$-33.58M
KGV:
-31.84
EPS:
-0.96
Netto-Cashflow:
$-20.74M
1W Leistung:
-3.11%
1M Leistung:
+1.97%
6M Leistung:
-16.38%
1J Leistung:
+46.62%
1-Tages-Spanne:
Value
$30.38
$31.74
1-Wochen-Bereich:
Value
$29.78
$32.46
52-Wochen-Spanne:
Value
$20.85
$59.23

Harrow Inc Stock (HROW) Company Profile

Name
Firmenname
Harrow Inc
Name
Telefon
615.733.4731
Name
Adresse
1A BURTON HILLS BLVD, NASHVILLE, CA
Name
Mitarbeiter
382
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-17
Name
Neueste SEC-Einreichungen
Name
HROW's Discussions on Twitter

Vergleichen Sie HROW mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
HROW
Harrow Inc
30.57 1.14B 154.15M -33.58M -20.74M -0.96
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
10.36 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
159.08 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.26 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.42 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.05 20.17B 16.54B -1.64B 749.00M -1.45

Harrow Inc Stock (HROW) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-12 Eingeleitet BTIG Research Buy
2025-06-10 Eingeleitet William Blair Outperform
2025-02-06 Eingeleitet H.C. Wainwright Buy
2024-12-04 Bestätigt B. Riley Securities Buy
2024-04-11 Eingeleitet Craig Hallum Buy
2022-09-08 Fortgesetzt B. Riley Securities Buy
2021-10-14 Fortgesetzt B. Riley Securities Buy
2021-09-24 Eingeleitet Aegis Capital Buy
2021-07-02 Eingeleitet Ladenburg Thalmann Buy
Alle ansehen

Harrow Inc Aktie (HROW) Neueste Nachrichten

pulisher
Jun 18, 2025

HROW to Participate in Lake Street's Virtual Meeting on June 24 - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications | HROW Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications - Business Wire

Jun 18, 2025
pulisher
Jun 17, 2025

Opaleye Management Inc. Adjusts Holdings in Harrow Inc. - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Harrow wins new Outperform at William Blair after licensing deal for pain drug - MSN

Jun 16, 2025
pulisher
Jun 12, 2025

HARROW HEALTH SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their Options - The Globe and Mail

Jun 12, 2025
pulisher
Jun 12, 2025

BTIG Initiates Harrow at Buy With $62 Price Target - MarketScreener

Jun 12, 2025
pulisher
Jun 11, 2025

BTIG Initiates Coverage of Harrow (HROW) with Optimistic Outlook - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Harrow Inc. sees $923,827 in stock sales by major shareholder - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

BTIG Initiates Coverage of Harrow (HROW) with Optimistic Outlook | HROW Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

William Blair Bullish On Harrow's High-Margin Branded Eye Drug Strategy - Benzinga

Jun 11, 2025
pulisher
Jun 10, 2025

HARROW HEALTH INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their Options - The Globe and Mail

Jun 10, 2025
pulisher
Jun 10, 2025

Harrow acquires U.S. commercial rights to BYQLOVI from Formosa Pharmaceuticals - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Harrow (HROW) Gains Coverage with Outperform Rating Following Licensing Deal - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Harrow stock wins William Blair's new Outperform (HROW:NASDAQ) - Seeking Alpha

Jun 10, 2025
pulisher
Jun 10, 2025

Assessing Harrow: Insights From 4 Financial Analysts - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Lake Street Remains a Buy on Harrow Health (HROW) - The Globe and Mail

Jun 10, 2025
pulisher
Jun 10, 2025

William Blair Initiates Coverage on Harrow (HROW) with Outperfor - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

William Blair Initiates Coverage on Harrow With Outperform Rating - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

William Blair Initiates Outperform Rating for Harrow (HROW) | HR - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

William Blair Initiates Outperform Rating for Harrow (HROW) | HROW Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals - mx.advfn.com

Jun 09, 2025
pulisher
Jun 09, 2025

Harrow (HROW) Secures Exclusive U.S. Rights for New Ophthalmic S - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Harrow (HROW) Secures U.S. Rights to BYQLOVI - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Harrow Acquires US Commercial Rights for Byqlovi From Formosa Pharmaceuticals - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Harrow Acquires U.S. Commercial Rights To Byqlovi(TM) From Formosa Pharmaceuticals - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

HROW Signs Licensing Agreement for Exclusive U.S. Rights to Byqlovi 0.05% | HROW Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 08, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 29,262 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Harrow Inc (HROW) Shares Down 5.39% on Jun 5 - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Bank of America Corp DE Trims Stock Holdings in Harrow, Inc. (NASDAQ:HROW) - Defense World

Jun 05, 2025
pulisher
Jun 02, 2025

Millennium Management LLC Sells 101,671 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

B. Riley Issues Pessimistic Forecast for Harrow Earnings - Defense World

May 31, 2025
pulisher
May 30, 2025

Insiders Favor Harrow And 2 Other Leading Growth Companies - Yahoo Finance

May 30, 2025
pulisher
May 30, 2025

Harrow Inc (HROW) Shares Up 4.04% on May 30 - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Obituary for Douglas "Doug" A. Harrow - Schaffer Funeral Home, Inc.

May 30, 2025
pulisher
May 28, 2025

Harrow: Epic Growth & Operating Leverage On Full Display (NASDAQ:HROW) - Seeking Alpha

May 28, 2025
pulisher
May 23, 2025

Harrow Inc (HROW) Stock Price Down 3.78% on May 22 - GuruFocus

May 23, 2025
pulisher
May 21, 2025

Deutsche Bank AG Has $3.63 Million Holdings in Harrow, Inc. (NASDAQ:HROW) - Defense World

May 21, 2025
pulisher
May 18, 2025

The Manufacturers Life Insurance Company Has $372,000 Holdings in Harrow, Inc. (NASDAQ:HROW) - Defense World

May 18, 2025
pulisher
May 16, 2025

Harrow Inc (HROW) Stock Price Up 8.35% on May 16 - GuruFocus

May 16, 2025
pulisher
May 15, 2025

Harrow Inc.: Opaleye management sells $150,055 in stock - Investing.com Australia

May 15, 2025
pulisher
May 14, 2025

Harrow Inc.: Opaleye management sells $150,055 in stock By Investing.com - Investing.com India

May 14, 2025
pulisher
May 14, 2025

Jim Cramer on Harrow, Inc. (HROW) – “Eye Care’s a Good Biz – If It Makes Money, Don’t Walk Away Pre-Breakout” - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

Harrow to Present at Two Investor Conferences in May - Business Wire

May 14, 2025
pulisher
May 13, 2025

Jim Cramer Is 'OK' With Harrow, Recommends Buying This Energy Stock - Benzinga

May 13, 2025
pulisher
May 13, 2025

Harrow Health, Inc. (NASDAQ:HROW) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 13, 2025

Harrow (HROW) Faces Price Target Cut Amid Q1 Earnings Miss | HRO - GuruFocus

May 13, 2025
pulisher
May 13, 2025

HROW Stock Price Target Raised to $60 by Analyst | HROW Stock Ne - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Price T Rowe Associates Inc. MD Buys 1,428 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World

May 13, 2025
pulisher
May 13, 2025

Harrow (NASDAQ:HROW) Price Target Raised to $60.00 at HC Wainwright - Defense World

May 13, 2025
pulisher
May 12, 2025

Where Harrow Stands With Analysts - Benzinga

May 12, 2025

Finanzdaten der Harrow Inc-Aktie (HROW)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Harrow Inc-Aktie (HROW) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Opaleye Management Inc.
10% Owner
Jun 09 '25
Sale
30.37
15,204
461,794
105,000
Opaleye Management Inc.
10% Owner
Jun 03 '25
Sale
30.04
3,000
90,116
122,000
Opaleye Management Inc.
10% Owner
Jun 04 '25
Sale
30.02
1,796
53,907
120,204
Opaleye Management Inc.
10% Owner
May 12 '25
Sale
25.90
10,000
258,959
130,000
Opaleye Management Inc.
10% Owner
May 13 '25
Sale
26.59
5,000
132,945
125,000
BOLL ANDREW R.
Chief Financial Officer
Apr 03 '25
Option Exercise
0.00
346,500
0
914,589
SAHAREK JOHN P.
CEO & President, ImprimisRx
Apr 03 '25
Option Exercise
0.00
277,200
0
576,863
BAUM MARK L
Chief Executive Officer
Apr 03 '25
Option Exercise
0.00
762,300
0
2,899,825
Opaleye Management Inc.
10% Owner
Mar 18 '25
Sale
30.01
5,000
150,055
140,000
Opaleye Management Inc.
10% Owner
Mar 18 '25
Sale
29.64
5,000
148,200
145,000
$14.72
price up icon 2.01%
$9.34
price up icon 1.74%
$129.40
price up icon 1.09%
$295.22
price up icon 1.48%
drug_manufacturers_specialty_generic RDY
$14.88
price down icon 0.40%
$17.05
price up icon 2.46%
Kapitalisierung:     |  Volumen (24h):